Analysis of WAVE3 expression levels in the blood of 200 BC patients and correlation with the patients’ clinical data revealed that (i) WAVE3 mRNA is highly expressed in the peripheral blood of patients with metastatic breast cancer, and (ii) WAVE3 expression levels in the blood of BC patients correlates positively with the aggressive TNBC subtype. This evidence concerns the gene WASF3 and breast cancer.